The 2023 International Porphyrias Symposium is now accepting abstract submissions through September 1, 2023.
Organizers anticipate selecting up to 6 abstracts for oral presentations throughout the meeting. Please specify whether you would like your abstract considered for oral presentation, poster presentation or both.
The abstract should be one paragraph with a maximum length of 400 words. The abstract should aim to succinctly describe the background, methodology, key results, and main conclusions drawn from the results. Kindly note that a maximum of two (2) abstracts will be accepted per primary/main author, and that the submitted abstracts should contain text only (i.e., no figures). Please do not use proprietary drug names in the abstract.